￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Tepotinib (Tepmetko) approved for marketing for the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Tepotinib in the treatment of MET-positive NSCLC with meningeal metastasis _ Kanghule

2025-10-19 11:44:20

Check Details
Anti-angiogenesis inhibitor: ramucirumab!

2025-10-19 11:44:20

Check Details
How effective is ramucirumab? What are the side effects of ramucirumab?

2025-10-19 11:44:20

Check Details
Early detection may reduce mortality in lung cancer patients

2025-10-19 11:44:20

Check Details
Targeting METex14 jumping mutations! New drug for non-small cell lung cancer, Tepotinib (Tepmetko) _ Kanghule

2025-10-19 11:44:20

Check Details
The legendary anti-cancer drug larotrectinib is approved by the FDA!

2025-10-19 11:44:20

Check Details
How effective is larotinib? What are the side effects of larotinib?

2025-10-19 11:44:20

Check Details
How much does a box of Tepotinib Hydrochloride Tablets cost? Is it sold in Beijing

2025-10-19 11:44:20

Check Details
Can Tepotinib Hydrochloride Tablets (Tepotinib) prolong the survival of patients?

2025-10-19 11:44:20

Check Details
Which generation of targeted drug is icotinib? How to use?

2025-10-19 11:44:20

Check Details
FDA Grants Breakthrough Therapy Designation to CLN-081 for EGFR Mutated NSCLC

2025-10-19 11:44:20

Check Details
Category
相关知识